P3 Health Partners Inc.
PIII
$0.1851
-$0.0009-0.48%
09/30/2024 | 06/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -4.49% | -2.40% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -4.49% | -2.40% | |||
Cost of Revenue | 10.06% | -4.42% | |||
Gross Profit | -384.54% | 117.48% | |||
SG&A Expenses | 24.16% | -2.52% | |||
Depreciation & Amortization | -0.09% | 0.71% | |||
Other Operating Expenses | 634.82% | -439.70% | |||
Total Operating Expenses | 15.79% | -5.05% | |||
Operating Income | -261.24% | 28.51% | |||
Income Before Tax | -282.85% | 41.50% | |||
Income Tax Expenses | -472.42% | -53.28% | |||
Earnings from Continuing Operations | -257.44% | 41.99% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | 236.27% | -45.79% | |||
Net Income | -286.96% | 35.72% | |||
EBIT | -261.24% | 28.51% | |||
EBITDA | -849.25% | 56.75% | |||
EPS Basic | -226.48% | 44.06% | |||
Normalized Basic EPS | -1,789.13% | -145.54% | |||
EPS Diluted | -113.03% | 7.88% | |||
Normalized Diluted EPS | -1,840.91% | -143.56% | |||
Average Basic Shares Outstanding | 18.51% | 14.90% | |||
Average Diluted Shares Outstanding | 16.74% | 18.67% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |